Dimitrios Evangelopoulos

7PUBLICATIONS
13CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsMycologyMedical biotechnology diagnostics (incl. biosensors)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 22, 2026
Activation of L-histidine biosynthesis as a new antibiotic strategy against Mycobacterium tuberculosis.

Debbie M Hunt, João Pedro Pisco, Angela Rodgers

|Mar 26, 2022
Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis.

Hasmik Margaryan, Dimitrios D Evangelopoulos, Leticia Muraro Wildner

|Feb 25, 2022
Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development.

Dimitrios Evangelopoulos, Carolyn M Shoen, Isobella Honeyborne

|Apr 30, 2021
New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis.

Sarentha Chetty, Tom Armstrong, Shalu Sharma Kharkwal

|Sep 15, 2019
Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes.

Dimitrios Evangelopoulos, Gareth A Prosser, Angela Rodgers

|Apr 06, 2017
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.

Ali Ryan, Elena Polycarpou, Nathan A Lack

Pageof 2

Frequent Collaborators

3 joint publications

Timothy D McHugh

2 joint publications

Maximiliano G Gutierrez

2 joint publications

Luiz Pedro S de Carvalho

1 joint publications

Ali Ryan